• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Wednesday

    6/14/23 1:13:07 PM ET
    $AKU
    $AY
    $BENF
    $BIOC
    Medical Specialities
    Health Care
    Electric Utilities: Central
    Utilities
    Get the next $AKU alert in real time by email

     

    On Wednesday, 33 stocks hit new 52-week lows.

    Interesting Facts About Today's 52-Week Lows:

    • The largest company by market cap to set a new 52-week low was UnitedHealth Group (NYSE:UNH).
    • Biocept (NASDAQ:BIOC) was the smallest, in terms of market cap, to set a new 52-week low.
    • Tenon Medical (NASDAQ:TNON) shares traded down 51.96% to reach its 52-week low, making it the biggest loser.
    • Camber Energy (AMEX:CEI) shares actually gained 0.16%, rebounding after it reached its 52-week low.

    The stocks that set new 52-week lows on Wednesday:

    • UnitedHealth Group (NYSE:UNH) stock dropped to a yearly low on Wednesday of $445.83. Shares traded down 7.25%.
    • Atlantica Sustainable (NASDAQ:AY) stock drifted down 1.08% on Wednesday morning to hit a new 52-week low of $23.70.
    • Beneficient (NASDAQ:BENF) stock set a new 52-week low of $5.21 on Wednesday, moving down 7.19%.
    • PolyMet Mining (AMEX:PLM) shares hit a yearly low of $0.82. The stock was up 0.22% on the session.
    • Intevac (NASDAQ:IVAC) stock drifted down 13.84% on Wednesday morning to hit a new 52-week low of $3.68.
    • Precision BioSciences (NASDAQ:DTIL) shares hit a yearly low of $0.66. The stock was down 3.52% on the session.
    • Mullen Automotive (NASDAQ:MULN) shares made a new 52-week low of $0.27 on Wednesday. The stock was down 12.88% for the day.
    • FLJ Group (NASDAQ:FLJ) shares hit a yearly low of $0.28. The stock was down 13.73% on the session.
    • Great Elm Capital (NASDAQ:GECC) shares made a new 52-week low of $7.55 on Wednesday. The stock was down 3.5% for the day.
    • Passage Bio (NASDAQ:PASG) shares set a new 52-week low of $0.93. The stock traded down 0.75%.
    • IO Biotech (NASDAQ:IOBT) shares hit a yearly low of $1.58. The stock was down 19.66% on the session.
    • Upexi (NASDAQ:UPXI) shares set a new yearly low of $2.04 this morning. The stock was down 6.74% on the session.
    • Trio Petroleum (AMEX:TPET) stock hit $1.30 on Wednesday morning, setting a new 52-week low for a change of down 2.96%.
    • Akumin (NASDAQ:AKU) shares reached a new 52-week low of $0.33 on Wednesday morning, moving up 2.19%.
    • Castellum (AMEX:CTM) shares fell to $0.56 on Wednesday, setting a new 52-week low with a shift of down 4.72%.
    • Camber Energy (AMEX:CEI) stock hit a new 52-week low of $1.00. The stock was up 0.16% on the session.
    • iClick Interactive Asia (NASDAQ:ICLK) stock hit $2.05 on Wednesday morning, setting a new 52-week low for a change of down 4.66%.
    • Cineverse (NASDAQ:CNVS) stock hit $2.20 on Wednesday morning, setting a new 52-week low for a change of down 35.53%.
    • SMX (Security Matters) (NASDAQ:SMX) shares fell to $0.62 on Wednesday, setting a new 52-week low with a shift of down 17.84%.
    • Bluejay Diagnostics (NASDAQ:BJDX) stock hit a yearly low of $0.19. The stock was down 4.55% for the day.
    • OceanPal (NASDAQ:OP) shares reached a new 52-week low of $2.53 on Wednesday morning, moving down 7.66%.
    • TC BioPharm (Holdings) (NASDAQ:TCBP) shares set a new yearly low of $0.59 this morning. The stock was up 1.37% on the session.
    • INVO Bioscience (NASDAQ:INVO) stock hit a yearly low of $0.15. The stock was down 5.27% for the day.
    • Biocept (NASDAQ:BIOC) stock set a new 52-week low of $1.64 on Wednesday, moving down 2.58%.

    Be sure to stay with Benzinga for further updates and market-moving news. And if you want to be among the first to know about the 52-week highs and lows for the day, check out Benzinga Pro. Users receive a daily alert listing stocks trading near 52-week highs and lows each morning. Click here to learn more.

    Get the next $AKU alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AKU
    $AY
    $BENF
    $BIOC

    CompanyDatePrice TargetRatingAnalyst
    UnitedHealth Group Incorporated
    $UNH
    10/29/2025$333.00Buy → Hold
    Deutsche Bank
    UnitedHealth Group Incorporated
    $UNH
    10/14/2025$406.00Buy
    Goldman
    IO Biotech Inc.
    $IOBT
    9/30/2025$0.39Overweight → Equal-Weight
    Morgan Stanley
    IO Biotech Inc.
    $IOBT
    9/30/2025Buy → Hold
    TD Cowen
    Upexi Inc.
    $UPXI
    8/4/2025$15.00Buy
    Alliance Global Partners
    UnitedHealth Group Incorporated
    $UNH
    7/31/2025$198.00Neutral → Underperform
    Robert W. Baird
    UnitedHealth Group Incorporated
    $UNH
    7/30/2025$400.00 → $325.00Outperform
    Oppenheimer
    Upexi Inc.
    $UPXI
    6/16/2025$16.00Neutral → Overweight
    Cantor Fitzgerald
    More analyst ratings

    $AKU
    $AY
    $BENF
    $BIOC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Salkind Gene bought $127,500 worth of shares (50,000 units at $2.55) (SEC Form 4)

    4 - UPEXI, INC. (0001775194) (Issuer)

    11/21/25 6:32:50 AM ET
    $UPXI
    Medicinal Chemicals and Botanical Products
    Health Care

    Director Salkind Gene bought $546,000 worth of shares (200,000 units at $2.73), increasing direct ownership by 21% to 569,470 units (SEC Form 4)

    4 - UPEXI, INC. (0001775194) (Issuer)

    11/18/25 9:40:18 PM ET
    $UPXI
    Medicinal Chemicals and Botanical Products
    Health Care

    CEO and President Foster Steven M bought 19,455 shares, increasing direct ownership by 568% to 22,878 units (SEC Form 4)

    4 - Tenon Medical, Inc. (0001560293) (Issuer)

    11/18/25 8:42:50 PM ET
    $TNON
    Medical/Dental Instruments
    Health Care

    $AKU
    $AY
    $BENF
    $BIOC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Remeasuring Biotech Pipelines: The Valuation Signal Investors Have Been Waiting For

    AUSTIN, Texas, Nov. 20, 2025 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: As late-stage biotech pipelines mature, fair-value remeasurements under U.S. Generally Accepted Accounting Principles (GAAP) are emerging as critical indicators of tangible scientific and commercial progress. These revaluations provide a financial bridge between laboratory breakthroughs and shareholder value, offering investors a clearer picture of how innovation becomes measurable enterprise worth. Oncotelic Therapeutics Inc. (OTCQB:OTLC) (profile) exemplifies this shift as the company prepares for a significant fair-value remeasurement of its 45% stake in joint venture (JV) entity GMP Bio, driven by a new ind

    11/20/25 8:30:00 AM ET
    $BCAX
    $IOBT
    $NVS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Precision BioSciences Announces Presentation of Clinical Data from the ELIMINATE-B Trial at HEP-DART 2025

    Precision BioSciences, Inc. (NASDAQ:DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases, today announced that it will deliver an oral presentation at the Hep-DART 2025 meeting, to take place December 7–11, 2025, at the Hilton Hawaiian Village in Honolulu, Hawaii. The presentation will feature data from the Phase 1 ELIMINATE-B trial of PBGENE-HBV. "We are pleased to share the latest clinical results from ELIMINATE-B with the international hepatology community at Hep-DART 2025," said Dr. Cassie Gorsuch, Chief Scientific Officer of Precision BioSciences. "Chronic hepatitis B contin

    11/19/25 7:01:00 AM ET
    $DTIL
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    JoySauce and Cineverse Launch New Streaming Network Dedicated to 'American Asian' Entertainment

    First Ever FAST Channel for the AAPI Community Now Live on Amazon Prime Video Studio Series and Films Plus JoySauce Originals — Available On Demand at JoySauce.TV, on YouTube and via Mobile Apps LOS ANGELES and SANTA MONICA, Calif., Nov. 18, 2025 /PRNewswire/ -- JoySauce, a leading lifestyle company for "American Asians" and all fans of broader Asian pop culture, and Cineverse (NASDAQ:CNVS), a next-generation entertainment studio, today launched the JoySauce Network.  Available today initially on Amazon Prime Video's live channels lineup is the first-ever free, ad-supported st

    11/18/25 9:00:00 AM ET
    $CNVS
    Consumer Electronics/Video Chains
    Consumer Discretionary

    $AKU
    $AY
    $BENF
    $BIOC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    UnitedHealth downgraded by Deutsche Bank with a new price target

    Deutsche Bank downgraded UnitedHealth from Buy to Hold and set a new price target of $333.00

    10/29/25 7:53:31 AM ET
    $UNH
    Medical Specialities
    Health Care

    Goldman initiated coverage on UnitedHealth with a new price target

    Goldman initiated coverage of UnitedHealth with a rating of Buy and set a new price target of $406.00

    10/14/25 8:54:29 AM ET
    $UNH
    Medical Specialities
    Health Care

    IO Biotech downgraded by TD Cowen

    TD Cowen downgraded IO Biotech from Buy to Hold

    9/30/25 8:32:59 AM ET
    $IOBT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AKU
    $AY
    $BENF
    $BIOC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Salkind Gene bought $127,500 worth of shares (50,000 units at $2.55) (SEC Form 4)

    4 - UPEXI, INC. (0001775194) (Issuer)

    11/21/25 6:32:50 AM ET
    $UPXI
    Medicinal Chemicals and Botanical Products
    Health Care

    Chief Financial Officer Norstrud Andrew James was granted 240,000 shares, increasing direct ownership by 59% to 649,138 units (SEC Form 4)

    4 - UPEXI, INC. (0001775194) (Issuer)

    11/21/25 6:32:36 AM ET
    $UPXI
    Medicinal Chemicals and Botanical Products
    Health Care

    Director Salkind Gene bought $546,000 worth of shares (200,000 units at $2.73), increasing direct ownership by 21% to 569,470 units (SEC Form 4)

    4 - UPEXI, INC. (0001775194) (Issuer)

    11/18/25 9:40:18 PM ET
    $UPXI
    Medicinal Chemicals and Botanical Products
    Health Care

    $AKU
    $AY
    $BENF
    $BIOC
    SEC Filings

    View All

    UnitedHealth Group Incorporated filed SEC Form 8-K: Leadership Update

    8-K - UNITEDHEALTH GROUP INC (0000731766) (Filer)

    11/21/25 5:20:04 PM ET
    $UNH
    Medical Specialities
    Health Care

    SEC Form 8-K filed by IO Biotech Inc.

    8-K - IO Biotech, Inc. (0001865494) (Filer)

    11/21/25 4:44:15 PM ET
    $IOBT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 8-K filed by IO Biotech Inc.

    8-K - IO Biotech, Inc. (0001865494) (Filer)

    11/18/25 6:30:19 AM ET
    $IOBT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AKU
    $AY
    $BENF
    $BIOC
    Leadership Updates

    Live Leadership Updates

    View All

    Upexi Welcomes Jon Najarian to the Upexi Advisory Committee

    TAMPA, Fla., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Upexi, Inc. (NASDAQ:UPXI), a brand owner specializing in the development, manufacturing, and distribution of consumer products with diversification into the cryptocurrency space, today announced the addition of Jon Najarian (Twitter: @jonnajarian) to the Upexi Advisory Committee, joining Arthur Hayes and S◎L Big Brain as founding Upexi Advisory Committee members. Jon Najarian is a highly influential figure in the world of finance, renowned for his deep expertise in options trading and market strategy. A former professional football player, Jon co-founded options trading firm Mercury Trading and later launched financial education company Marke

    10/23/25 8:00:00 AM ET
    $UPXI
    Medicinal Chemicals and Botanical Products
    Health Care

    Cineverse Technology Group Launches Matchpoint™ 3.0 with New Features, Brand Identity

    LOS ANGELES, Oct. 6, 2025 /PRNewswire/ -- Cineverse Corp (NASDAQ:CNVS), a next-generation entertainment studio, has today launched Matchpoint™ 3.0, the newest version of the Company's proprietary, state-of-the-art, automated media supply chain platform that is radically changing the way video content is managed and delivered.  This comes with the launch of a new brand identity, seen now at www.matchpoint.tv, updating and modernizing the UI's look-and-feel, making it easier-to-use for customers.  Trusted by top studios and streaming platforms, Matchpoint is leading the evolutio

    10/6/25 1:15:00 PM ET
    $CNVS
    Consumer Electronics/Video Chains
    Consumer Discretionary

    Twilio Set to Join S&P MidCap 400

    NEW YORK, Aug. 14, 2025 /PRNewswire/ -- Twilio Inc. (NYSE:TWLO) will replace Amedisys Inc. (NASD: AMED) in the S&P MidCap 400 effective prior to the opening of trading on Tuesday, August 19. S&P 500 and S&P 100 constituent UnitedHealth Group Inc. (NYSE:UNH) acquired Amedisys in a deal completed today. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name       Action Company Name Ticker GICS Sector August 19, 2025 S&P MidCap 400 Addition Twilio TWLO Information Technology August 19, 2025 S&P MidCap 400 Deletion Amedisys AMED Health Care For more information about S&P Dow Jones Indices, please visit www.spdji

    8/14/25 6:08:00 PM ET
    $AMED
    $SPGI
    $TWLO
    Medical/Nursing Services
    Health Care
    Finance: Consumer Services
    Finance

    $AKU
    $AY
    $BENF
    $BIOC
    Financials

    Live finance-specific insights

    View All

    Beneficient Reports Results for Second Quarter Fiscal 2026

    DALLAS, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Beneficient (NASDAQ:BENF) ("Ben" or the "Company"), a technology-enabled platform providing exit opportunities and primary capital solutions and related trust and custody services to holders of alternative assets, today reported its financial results for the fiscal 2026 second quarter, which ended September 30, 2025. Commenting on the fiscal 2026 second quarter results, interim Chief Executive Officer James Silk said: "The second quarter results demonstrate our disciplined approach to managing both our investment portfolio and operating expenses during a pivotal period for Beneficient. We reduced expenses, completed new primary capital transaction

    11/14/25 5:15:00 PM ET
    $BENF
    Finance: Consumer Services
    Finance

    Cineverse Reports Second Quarter Fiscal Year 2026 Results

    Total Revenue of $12.4 Million Direct Operating Margin of 58%, a 7% Improvement over Prior Year Quarter LOS ANGELES, Nov. 14, 2025 /PRNewswire/ -- Cineverse Corp. ("Cineverse" or the "Company") (NASDAQ:CNVS), a next-generation entertainment studio, today announced its financial results for its second quarter ended September 30, 2025 ("Q2 FY 2026"): Total Revenue declined 3% year-over-year, primarily reflecting differences in the timing of revenue recognition for certain content licensing agreements. In the prior-year quarter, the Company recorded $1.6 million from a Dog Whispe

    11/14/25 4:08:00 PM ET
    $CNVS
    Consumer Electronics/Video Chains
    Consumer Discretionary

    Upexi Reports Record Digital Asset Revenue for Fiscal First Quarter 2026

    Digital Asset Revenue was Approximately $6.1 Million for the Quarter Gross Profit Totaled $8.3 Million, up 183% Year-Over-Year Net Income Increased to $66.7 Million, Compared to a Net Loss of $1.6 Million, Year-over-Year Conference Call Scheduled for today, November 11, 2025, at 5:30 p.m. Eastern Time TAMPA, Fla., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Upexi, Inc. (NASDAQ:UPXI) ("Upexi" or the "Company"), a leading Solana-focused digital asset treasury company and consumer brands owner, today announced record digital asset revenue for the fiscal first quarter ended September 30, 2025. Financial Highlights for the Quarter Ended September 30, 2025 Total revenue for the quarter was $9.2 mill

    11/11/25 5:25:00 PM ET
    $UPXI
    Medicinal Chemicals and Botanical Products
    Health Care

    $AKU
    $AY
    $BENF
    $BIOC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Great Elm Capital Corp.

    SC 13D/A - Great Elm Capital Corp. (0001675033) (Subject)

    12/13/24 6:47:34 PM ET
    $GECC
    Finance: Consumer Services
    Finance

    Amendment: SEC Form SC 13D/A filed by Atlantica Sustainable Infrastructure plc

    SC 13D/A - Atlantica Sustainable Infrastructure plc (0001601072) (Subject)

    12/12/24 12:30:42 PM ET
    $AY
    Electric Utilities: Central
    Utilities

    SEC Form SC 13G filed by Great Elm Capital Corp.

    SC 13G - Great Elm Capital Corp. (0001675033) (Subject)

    12/12/24 8:44:54 AM ET
    $GECC
    Finance: Consumer Services
    Finance